Madeleine Farman
Madeleine Farman is a senior reporter for PEI Group’s Private Equity International and Secondaries Investor titles, based in London. Prior to joining PEI, she had covered private equity, private capital and advisers associated with the industry for other newsrooms and publications since 2016. Originally from New Zealand, Madeleine began her career in radio in Auckland.
ArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €2.4bn.
Tender offers plus staples can be a powerful tool to provide liquidity to cash-strapped LPs.
The life sciences unit increased its original €175m hard-cap to allow for more investment into the portfolio companies it seeks to back.
Three family offices will acquire a 20% stake in Armen, which was founded last year by Ardian’s Dominique Gaillard and Capza’s Laurent Bénard.
There is misalignment between investors and GPs on the topics of obstacles, red flags and expectations, a Capstone survey finds.
Buyers are increasingly splitting out their fund strategies as institutional investors seek specific risk/reward categories for secondaries.
Conditions are favourable for deal-by-deal transactions, adding to the growing ocean of manager types in an already competitive market.
PEI’s annual investor survey indicates that LPs aren’t rushing to exit every deal, but they do expect third-party valuations.
The valuation process is key to determining the fair value of a GP’s portfolio. How is this undertaking managed?
Sweta Chattopadhyay, who joined Moonfare in 2020 from bfinance, is leaving the digital fundraising platform at the end of the month, PEI has learned.